Inhibition of hepatitis B virus via selective apoptosis modulation by Chinese patent medicine Liuweiwuling Tablet

doi:10.3748/wjg.v30.i13.1911

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 30, Issue 13

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3236)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-7) series, Tables (1-1) series.

Item

Count

PDF

HTML

1396

Figures (1-7)

247

Tables (1-1)

276

Sum=1978

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

242

Download

412

Sum=654

Publishing Process of This Article

Item

Count

Browse

107

Download

394

Sum=501

Apr 7, 2024 (publication date) through Jan 8, 2025

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastroenterol. Apr 7, 2024; 30(13): 1911-1925
Published online Apr 7, 2024. doi: 10.3748/wjg.v30.i13.1911

Table 1 Differentially expressed genes in Liuweiwuling Tablet anti-hepatitis B virus effects identified through transcriptomic analysis and validated by real-time reverse transcriptase-PCR

Gene	Fold change	P value	Is it related with apoptosis
E2F1	4.44770094	0.008685393	No
PCNA	4.047933076	0.002898892	No
CASP8	3.570355797	0.003000082	Yes
TP53	3.452487306	0.016679865	Yes
CREBBP	2.885252648	0.003455666	No
IKBKE	2.849255028	0.016173753	No
PIK3R3	2.815615387	0.011672063	Yes
CCNE2	2.506258474	0.014722413	No
BCL2	2.239207884	0.007566661	Yes
AKT3	2.023770673	0.003487678	Yes
CREB3L2	0.621889559	0.006920633	No
EGR2	0.44857779	0.001957335	No
FOS	0.183742709	0.02708347	Yes

Citation: Ge FL, Yang Y, Si LL, Li YH, Cao MZ, Wang J, Bai ZF, Ren ZG, Xiao XH, Liu Y. Inhibition of hepatitis B virus via selective apoptosis modulation by Chinese patent medicine Liuweiwuling Tablet. World J Gastroenterol 2024; 30(13): 1911-1925
URL: https://www.wjgnet.com/1007-9327/full/v30/i13/1911.htm
DOI: https://dx.doi.org/10.3748/wjg.v30.i13.1911